vorinostat has been researched along with Allergic Reaction in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melchior, M | 1 |
| Juif, PE | 1 |
| Gazzo, G | 1 |
| Petit-Demoulière, N | 1 |
| Chavant, V | 1 |
| Lacaud, A | 1 |
| Goumon, Y | 1 |
| Charlet, A | 1 |
| Lelièvre, V | 1 |
| Poisbeau, P | 1 |
1 other study available for vorinostat and Allergic Reaction
| Article | Year |
|---|---|
Pharmacological rescue of nociceptive hypersensitivity and oxytocin analgesia impairment in a rat model of neonatal maternal separation.
Topics: Action Potentials; Analgesics; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists; | 2018 |